Industry Research Reports

Part 1

Part 2

Part 3

Part 4

Part 5

Home > Reports > Pharma & Healthcare > Oral Rabies Vaccine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Oral Rabies Vaccine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Pharma & Healthcare

Published: 2025-03-02

Pages: 84 Pages

Report ld: 4361846

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

The global market for Oral Rabies Vaccine was estimated to be worth US$ 116 million in 2024 and is forecast to a readjusted size of US$ 415 million by 2031 with a CAGR of 20.3% during the forecast period 2025-2031.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Oral Rabies Vaccine Market Size(US$)

M= millions and B=billions

This report aims to provide a comprehensive presentation of the global market for Oral Rabies Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Oral Rabies Vaccine by region & country, by Type, and by Application.

The Oral Rabies Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Rabies Vaccine.

Market Segmentation

Report Metric
Details
Report Title
Oral Rabies Vaccine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Forecasted Market Size in 2031
US$ 415 million
CAGR(2025-2031)
20.3%
Market Size Available for Years
2025-2031
Global Oral Rabies Vaccine Companies Covered
Boehringer Ingelheim(Merial)
Ceva Santé Animale(Artemis Technologies)
Virbac
Global Oral Rabies Vaccine Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Oral Rabies Vaccine Market, Segment by Type
Modified Live Virus
Recombinant Vaccinia
Recombinant Adenovirus Vaccine
Global Oral Rabies Vaccine Market, Segment by Application
Government
Commercial
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Oral Rabies Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Oral Rabies Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Oral Rabies Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

1 Market Overview
    1.1 Oral Rabies Vaccine Product Introduction
    1.2 Global Oral Rabies Vaccine Market Size Forecast
        1.2.1 Global Oral Rabies Vaccine Sales Value (2020-2031)
        1.2.2 Global Oral Rabies Vaccine Sales Volume (2020-2031)
        1.2.3 Global Oral Rabies Vaccine Sales Price (2020-2031)
    1.3 Oral Rabies Vaccine Market Trends & Drivers
        1.3.1 Oral Rabies Vaccine Industry Trends
        1.3.2 Oral Rabies Vaccine Market Drivers & Opportunity
        1.3.3 Oral Rabies Vaccine Market Challenges
        1.3.4 Oral Rabies Vaccine Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Competitive Analysis by Company
    2.1 Global Oral Rabies Vaccine Players Revenue Ranking (2024)
    2.2 Global Oral Rabies Vaccine Revenue by Company (2020-2025)
    2.3 Global Oral Rabies Vaccine Players Sales Volume Ranking (2024)
    2.4 Global Oral Rabies Vaccine Sales Volume by Company Players (2020-2025)
    2.5 Global Oral Rabies Vaccine Average Price by Company (2020-2025)
    2.6 Key Manufacturers Oral Rabies Vaccine Manufacturing Base and Headquarters
    2.7 Key Manufacturers Oral Rabies Vaccine Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Oral Rabies Vaccine
    2.9 Oral Rabies Vaccine Market Competitive Analysis
        2.9.1 Oral Rabies Vaccine Market Concentration Rate (2020-2025)
        2.9.2 Global 5 and 10 Largest Manufacturers by Oral Rabies Vaccine Revenue in 2024
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Rabies Vaccine as of 2024)
    2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Modified Live Virus
        3.1.2 Recombinant Vaccinia
        3.1.3 Recombinant Adenovirus Vaccine
    3.2 Global Oral Rabies Vaccine Sales Value by Type
        3.2.1 Global Oral Rabies Vaccine Sales Value by Type (2020 VS 2024 VS 2031)
        3.2.2 Global Oral Rabies Vaccine Sales Value, by Type (2020-2031)
        3.2.3 Global Oral Rabies Vaccine Sales Value, by Type (%) (2020-2031)
    3.3 Global Oral Rabies Vaccine Sales Volume by Type
        3.3.1 Global Oral Rabies Vaccine Sales Volume by Type (2020 VS 2024 VS 2031)
        3.3.2 Global Oral Rabies Vaccine Sales Volume, by Type (2020-2031)
        3.3.3 Global Oral Rabies Vaccine Sales Volume, by Type (%) (2020-2031)
    3.4 Global Oral Rabies Vaccine Average Price by Type (2020-2031)

4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Government
        4.1.2 Commercial
    4.2 Global Oral Rabies Vaccine Sales Value by Application
        4.2.1 Global Oral Rabies Vaccine Sales Value by Application (2020 VS 2024 VS 2031)
        4.2.2 Global Oral Rabies Vaccine Sales Value, by Application (2020-2031)
        4.2.3 Global Oral Rabies Vaccine Sales Value, by Application (%) (2020-2031)
    4.3 Global Oral Rabies Vaccine Sales Volume by Application
        4.3.1 Global Oral Rabies Vaccine Sales Volume by Application (2020 VS 2024 VS 2031)
        4.3.2 Global Oral Rabies Vaccine Sales Volume, by Application (2020-2031)
        4.3.3 Global Oral Rabies Vaccine Sales Volume, by Application (%) (2020-2031)
    4.4 Global Oral Rabies Vaccine Average Price by Application (2020-2031)

5 Segmentation by Region
    5.1 Global Oral Rabies Vaccine Sales Value by Region
        5.1.1 Global Oral Rabies Vaccine Sales Value by Region: 2020 VS 2024 VS 2031
        5.1.2 Global Oral Rabies Vaccine Sales Value by Region (2020-2025)
        5.1.3 Global Oral Rabies Vaccine Sales Value by Region (2026-2031)
        5.1.4 Global Oral Rabies Vaccine Sales Value by Region (%), (2020-2031)
    5.2 Global Oral Rabies Vaccine Sales Volume by Region
        5.2.1 Global Oral Rabies Vaccine Sales Volume by Region: 2020 VS 2024 VS 2031
        5.2.2 Global Oral Rabies Vaccine Sales Volume by Region (2020-2025)
        5.2.3 Global Oral Rabies Vaccine Sales Volume by Region (2026-2031)
        5.2.4 Global Oral Rabies Vaccine Sales Volume by Region (%), (2020-2031)
    5.3 Global Oral Rabies Vaccine Average Price by Region (2020-2031)
    5.4 North America
        5.4.1 North America Oral Rabies Vaccine Sales Value, 2020-2031
        5.4.2 North America Oral Rabies Vaccine Sales Value by Country (%), 2024 VS 2031
    5.5 Europe
        5.5.1 Europe Oral Rabies Vaccine Sales Value, 2020-2031
        5.5.2 Europe Oral Rabies Vaccine Sales Value by Country (%), 2024 VS 2031
    5.6 Asia Pacific
        5.6.1 Asia Pacific Oral Rabies Vaccine Sales Value, 2020-2031
        5.6.2 Asia Pacific Oral Rabies Vaccine Sales Value by Region (%), 2024 VS 2031
    5.7 South America
        5.7.1 South America Oral Rabies Vaccine Sales Value, 2020-2031
        5.7.2 South America Oral Rabies Vaccine Sales Value by Country (%), 2024 VS 2031
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Oral Rabies Vaccine Sales Value, 2020-2031
        5.8.2 Middle East & Africa Oral Rabies Vaccine Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Oral Rabies Vaccine Sales Value Growth Trends, 2020 VS 2024 VS 2031
    6.2 Key Countries/Regions Oral Rabies Vaccine Sales Value
        6.2.1 Key Countries/Regions Oral Rabies Vaccine Sales Value, 2020-2031
        6.2.2 Key Countries/Regions Oral Rabies Vaccine Sales Volume, 2020-2031
    6.3 United States
        6.3.1 United States Oral Rabies Vaccine Sales Value, 2020-2031
        6.3.2 United States Oral Rabies Vaccine Sales Value by Type (%), 2024 VS 2031
        6.3.3 United States Oral Rabies Vaccine Sales Value by Application, 2024 VS 2031
    6.4 Europe
        6.4.1 Europe Oral Rabies Vaccine Sales Value, 2020-2031
        6.4.2 Europe Oral Rabies Vaccine Sales Value by Type (%), 2024 VS 2031
        6.4.3 Europe Oral Rabies Vaccine Sales Value by Application, 2024 VS 2031
    6.5 China
        6.5.1 China Oral Rabies Vaccine Sales Value, 2020-2031
        6.5.2 China Oral Rabies Vaccine Sales Value by Type (%), 2024 VS 2031
        6.5.3 China Oral Rabies Vaccine Sales Value by Application, 2024 VS 2031
    6.6 Japan
        6.6.1 Japan Oral Rabies Vaccine Sales Value, 2020-2031
        6.6.2 Japan Oral Rabies Vaccine Sales Value by Type (%), 2024 VS 2031
        6.6.3 Japan Oral Rabies Vaccine Sales Value by Application, 2024 VS 2031
    6.7 South Korea
        6.7.1 South Korea Oral Rabies Vaccine Sales Value, 2020-2031
        6.7.2 South Korea Oral Rabies Vaccine Sales Value by Type (%), 2024 VS 2031
        6.7.3 South Korea Oral Rabies Vaccine Sales Value by Application, 2024 VS 2031
    6.8 Southeast Asia
        6.8.1 Southeast Asia Oral Rabies Vaccine Sales Value, 2020-2031
        6.8.2 Southeast Asia Oral Rabies Vaccine Sales Value by Type (%), 2024 VS 2031
        6.8.3 Southeast Asia Oral Rabies Vaccine Sales Value by Application, 2024 VS 2031
    6.9 India
        6.9.1 India Oral Rabies Vaccine Sales Value, 2020-2031
        6.9.2 India Oral Rabies Vaccine Sales Value by Type (%), 2024 VS 2031
        6.9.3 India Oral Rabies Vaccine Sales Value by Application, 2024 VS 2031

7 Company Profiles
    7.1 Boehringer Ingelheim(Merial)
        7.1.1 Boehringer Ingelheim(Merial) Company Information
        7.1.2 Boehringer Ingelheim(Merial) Introduction and Business Overview
        7.1.3 Boehringer Ingelheim(Merial) Oral Rabies Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
        7.1.4 Boehringer Ingelheim(Merial) Oral Rabies Vaccine Product Offerings
        7.1.5 Boehringer Ingelheim(Merial) Recent Development
    7.2 Ceva Santé Animale(Artemis Technologies)
        7.2.1 Ceva Santé Animale(Artemis Technologies) Company Information
        7.2.2 Ceva Santé Animale(Artemis Technologies) Introduction and Business Overview
        7.2.3 Ceva Santé Animale(Artemis Technologies) Oral Rabies Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
        7.2.4 Ceva Santé Animale(Artemis Technologies) Oral Rabies Vaccine Product Offerings
        7.2.5 Ceva Santé Animale(Artemis Technologies) Recent Development
    7.3 Virbac
        7.3.1 Virbac Company Information
        7.3.2 Virbac Introduction and Business Overview
        7.3.3 Virbac Oral Rabies Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
        7.3.4 Virbac Oral Rabies Vaccine Product Offerings
        7.3.5 Virbac Recent Development

8 Industry Chain Analysis
    8.1 Oral Rabies Vaccine Industrial Chain
    8.2 Oral Rabies Vaccine Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Oral Rabies Vaccine Sales Model
        8.5.2 Sales Channel
        8.5.3 Oral Rabies Vaccine Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Oral Rabies Vaccine Market Trends
 Table 2. Oral Rabies Vaccine Market Drivers & Opportunity
 Table 3. Oral Rabies Vaccine Market Challenges
 Table 4. Oral Rabies Vaccine Market Restraints
 Table 5. Global Oral Rabies Vaccine Revenue by Company (2020-2025) & (US$ Million)
 Table 6. Global Oral Rabies Vaccine Revenue Market Share by Company (2020-2025)
 Table 7. Global Oral Rabies Vaccine Sales Volume by Company (2020-2025) & (K Units)
 Table 8. Global Oral Rabies Vaccine Sales Volume Market Share by Company (2020-2025)
 Table 9. Global Market Oral Rabies Vaccine Price by Company (2020-2025) & (US$/Unit)
 Table 10. Key Manufacturers Oral Rabies Vaccine Manufacturing Base and Headquarters
 Table 11. Key Manufacturers Oral Rabies Vaccine Product Type
 Table 12. Key Manufacturers Time to Begin Mass Production of Oral Rabies Vaccine
 Table 13. Global Oral Rabies Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Rabies Vaccine as of 2024)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Oral Rabies Vaccine Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Oral Rabies Vaccine Sales Value by Type (2020-2025) & (US$ Million)
 Table 18. Global Oral Rabies Vaccine Sales Value by Type (2026-2031) & (US$ Million)
 Table 19. Global Oral Rabies Vaccine Sales Market Share in Value by Type (2020-2025)
 Table 20. Global Oral Rabies Vaccine Sales Market Share in Value by Type (2026-2031)
 Table 21. Global Oral Rabies Vaccine Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
 Table 22. Global Oral Rabies Vaccine Sales Volume by Type (2020-2025) & (K Units)
 Table 23. Global Oral Rabies Vaccine Sales Volume by Type (2026-2031) & (K Units)
 Table 24. Global Oral Rabies Vaccine Sales Market Share in Volume by Type (2020-2025)
 Table 25. Global Oral Rabies Vaccine Sales Market Share in Volume by Type (2026-2031)
 Table 26. Global Oral Rabies Vaccine Price by Type (2020-2025) & (US$/Unit)
 Table 27. Global Oral Rabies Vaccine Price by Type (2026-2031) & (US$/Unit)
 Table 28. Global Oral Rabies Vaccine Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
 Table 29. Global Oral Rabies Vaccine Sales Value by Application (2020-2025) & (US$ Million)
 Table 30. Global Oral Rabies Vaccine Sales Value by Application (2026-2031) & (US$ Million)
 Table 31. Global Oral Rabies Vaccine Sales Market Share in Value by Application (2020-2025)
 Table 32. Global Oral Rabies Vaccine Sales Market Share in Value by Application (2026-2031)
 Table 33. Global Oral Rabies Vaccine Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
 Table 34. Global Oral Rabies Vaccine Sales Volume by Application (2020-2025) & (K Units)
 Table 35. Global Oral Rabies Vaccine Sales Volume by Application (2026-2031) & (K Units)
 Table 36. Global Oral Rabies Vaccine Sales Market Share in Volume by Application (2020-2025)
 Table 37. Global Oral Rabies Vaccine Sales Market Share in Volume by Application (2026-2031)
 Table 38. Global Oral Rabies Vaccine Price by Application (2020-2025) & (US$/Unit)
 Table 39. Global Oral Rabies Vaccine Price by Application (2026-2031) & (US$/Unit)
 Table 40. Global Oral Rabies Vaccine Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
 Table 41. Global Oral Rabies Vaccine Sales Value by Region (2020-2025) & (US$ Million)
 Table 42. Global Oral Rabies Vaccine Sales Value by Region (2026-2031) & (US$ Million)
 Table 43. Global Oral Rabies Vaccine Sales Value by Region (2020-2025) & (%)
 Table 44. Global Oral Rabies Vaccine Sales Value by Region (2026-2031) & (%)
 Table 45. Global Oral Rabies Vaccine Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
 Table 46. Global Oral Rabies Vaccine Sales Volume by Region (2020-2025) & (K Units)
 Table 47. Global Oral Rabies Vaccine Sales Volume by Region (2026-2031) & (K Units)
 Table 48. Global Oral Rabies Vaccine Sales Volume by Region (2020-2025) & (%)
 Table 49. Global Oral Rabies Vaccine Sales Volume by Region (2026-2031) & (%)
 Table 50. Global Oral Rabies Vaccine Average Price by Region (2020-2025) & (US$/Unit)
 Table 51. Global Oral Rabies Vaccine Average Price by Region (2026-2031) & (US$/Unit)
 Table 52. Key Countries/Regions Oral Rabies Vaccine Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
 Table 53. Key Countries/Regions Oral Rabies Vaccine Sales Value, (2020-2025) & (US$ Million)
 Table 54. Key Countries/Regions Oral Rabies Vaccine Sales Value, (2026-2031) & (US$ Million)
 Table 55. Key Countries/Regions Oral Rabies Vaccine Sales Volume, (2020-2025) & (K Units)
 Table 56. Key Countries/Regions Oral Rabies Vaccine Sales Volume, (2026-2031) & (K Units)
 Table 57. Boehringer Ingelheim(Merial) Company Information
 Table 58. Boehringer Ingelheim(Merial) Introduction and Business Overview
 Table 59. Boehringer Ingelheim(Merial) Oral Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 60. Boehringer Ingelheim(Merial) Oral Rabies Vaccine Product Offerings
 Table 61. Boehringer Ingelheim(Merial) Recent Development
 Table 62. Ceva Santé Animale(Artemis Technologies) Company Information
 Table 63. Ceva Santé Animale(Artemis Technologies) Introduction and Business Overview
 Table 64. Ceva Santé Animale(Artemis Technologies) Oral Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 65. Ceva Santé Animale(Artemis Technologies) Oral Rabies Vaccine Product Offerings
 Table 66. Ceva Santé Animale(Artemis Technologies) Recent Development
 Table 67. Virbac Company Information
 Table 68. Virbac Introduction and Business Overview
 Table 69. Virbac Oral Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 70. Virbac Oral Rabies Vaccine Product Offerings
 Table 71. Virbac Recent Development
 Table 72. Key Raw Materials Lists
 Table 73. Raw Materials Key Suppliers Lists
 Table 74. Oral Rabies Vaccine Downstream Customers
 Table 75. Oral Rabies Vaccine Distributors List
 Table 76. Research Programs/Design for This Report
 Table 77. Key Data Information from Secondary Sources
 Table 78. Key Data Information from Primary Sources


List of Figures
 Figure 1. Oral Rabies Vaccine Product Picture
 Figure 2. Global Oral Rabies Vaccine Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Oral Rabies Vaccine Sales Value (2020-2031) & (US$ Million)
 Figure 4. Global Oral Rabies Vaccine Sales Volume (2020-2031) & (K Units)
 Figure 5. Global Oral Rabies Vaccine Sales Price (2020-2031) & (US$/Unit)
 Figure 6. Oral Rabies Vaccine Report Years Considered
 Figure 7. Global Oral Rabies Vaccine Players Revenue Ranking (2024) & (US$ Million)
 Figure 8. Global Oral Rabies Vaccine Players Sales Volume Ranking (2024) & (K Units)
 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Oral Rabies Vaccine Revenue in 2024
 Figure 10. Oral Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 11. Modified Live Virus Picture
 Figure 12. Recombinant Vaccinia Picture
 Figure 13. Recombinant Adenovirus Vaccine Picture
 Figure 14. Global Oral Rabies Vaccine Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 15. Global Oral Rabies Vaccine Sales Value Market Share by Type, 2024 & 2031
 Figure 16. Global Oral Rabies Vaccine Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
 Figure 17. Global Oral Rabies Vaccine Sales Volume Market Share by Type, 2024 & 2031
 Figure 18. Global Oral Rabies Vaccine Price by Type (2020-2031) & (US$/Unit)
 Figure 19. Product Picture of Government
 Figure 20. Product Picture of Commercial
 Figure 21. Global Oral Rabies Vaccine Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 22. Global Oral Rabies Vaccine Sales Value Market Share by Application, 2024 & 2031
 Figure 23. Global Oral Rabies Vaccine Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
 Figure 24. Global Oral Rabies Vaccine Sales Volume Market Share by Application, 2024 & 2031
 Figure 25. Global Oral Rabies Vaccine Price by Application (2020-2031) & (US$/Unit)
 Figure 26. North America Oral Rabies Vaccine Sales Value (2020-2031) & (US$ Million)
 Figure 27. North America Oral Rabies Vaccine Sales Value by Country (%), 2024 VS 2031
 Figure 28. Europe Oral Rabies Vaccine Sales Value, (2020-2031) & (US$ Million)
 Figure 29. Europe Oral Rabies Vaccine Sales Value by Country (%), 2024 VS 2031
 Figure 30. Asia Pacific Oral Rabies Vaccine Sales Value, (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Oral Rabies Vaccine Sales Value by Region (%), 2024 VS 2031
 Figure 32. South America Oral Rabies Vaccine Sales Value, (2020-2031) & (US$ Million)
 Figure 33. South America Oral Rabies Vaccine Sales Value by Country (%), 2024 VS 2031
 Figure 34. Middle East & Africa Oral Rabies Vaccine Sales Value, (2020-2031) & (US$ Million)
 Figure 35. Middle East & Africa Oral Rabies Vaccine Sales Value by Country (%), 2024 VS 2031
 Figure 36. Key Countries/Regions Oral Rabies Vaccine Sales Value (%), (2020-2031)
 Figure 37. Key Countries/Regions Oral Rabies Vaccine Sales Volume (%), (2020-2031)
 Figure 38. United States Oral Rabies Vaccine Sales Value, (2020-2031) & (US$ Million)
 Figure 39. United States Oral Rabies Vaccine Sales Value by Type (%), 2024 VS 2031
 Figure 40. United States Oral Rabies Vaccine Sales Value by Application (%), 2024 VS 2031
 Figure 41. Europe Oral Rabies Vaccine Sales Value, (2020-2031) & (US$ Million)
 Figure 42. Europe Oral Rabies Vaccine Sales Value by Type (%), 2024 VS 2031
 Figure 43. Europe Oral Rabies Vaccine Sales Value by Application (%), 2024 VS 2031
 Figure 44. China Oral Rabies Vaccine Sales Value, (2020-2031) & (US$ Million)
 Figure 45. China Oral Rabies Vaccine Sales Value by Type (%), 2024 VS 2031
 Figure 46. China Oral Rabies Vaccine Sales Value by Application (%), 2024 VS 2031
 Figure 47. Japan Oral Rabies Vaccine Sales Value, (2020-2031) & (US$ Million)
 Figure 48. Japan Oral Rabies Vaccine Sales Value by Type (%), 2024 VS 2031
 Figure 49. Japan Oral Rabies Vaccine Sales Value by Application (%), 2024 VS 2031
 Figure 50. South Korea Oral Rabies Vaccine Sales Value, (2020-2031) & (US$ Million)
 Figure 51. South Korea Oral Rabies Vaccine Sales Value by Type (%), 2024 VS 2031
 Figure 52. South Korea Oral Rabies Vaccine Sales Value by Application (%), 2024 VS 2031
 Figure 53. Southeast Asia Oral Rabies Vaccine Sales Value, (2020-2031) & (US$ Million)
 Figure 54. Southeast Asia Oral Rabies Vaccine Sales Value by Type (%), 2024 VS 2031
 Figure 55. Southeast Asia Oral Rabies Vaccine Sales Value by Application (%), 2024 VS 2031
 Figure 56. India Oral Rabies Vaccine Sales Value, (2020-2031) & (US$ Million)
 Figure 57. India Oral Rabies Vaccine Sales Value by Type (%), 2024 VS 2031
 Figure 58. India Oral Rabies Vaccine Sales Value by Application (%), 2024 VS 2031
 Figure 59. Oral Rabies Vaccine Industrial Chain
 Figure 60. Oral Rabies Vaccine Manufacturing Cost Structure
 Figure 61. Channels of Distribution (Direct Sales, and Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed

Description

The global market for Oral Rabies Vaccine was estimated to be worth US$ 116 million in 2024 and is forecast to a readjusted size of US$ 415 million by 2031 with a CAGR of 20.3% during the forecast period 2025-2031.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Oral Rabies Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Oral Rabies Vaccine by region & country, by Type, and by Application.

The Oral Rabies Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Rabies Vaccine.

Market Segmentation

Related Reports

Global Oral Rabies Vaccine Market Research Report 2023
According to QYResearch’s new survey, global Oral Rabies Vaccine market is projected to reach US$ 29
Published: 2023-07-28
Pages: 71
USD 2900.00
(Single User License)
Global Oral Rabies Vaccine Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application
Oral Rabies Vaccine report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impa
Published: 2023-07-29
Pages: 73
USD 3350.00
(Single User License)
Global Oral Rabies Vaccine Market Insights, Forecast to 2029
Global Oral Rabies Vaccine market is expected to reach to US$ 98 million in 2023, with a positive gr
Published: 2023-08-28
Pages: 77
USD 4900.00
(Single User License)
Oral Rabies Vaccine - Global Market Insights and Sales Trends 2024
The global Oral Rabies Vaccine market size is expected to reach US$ 297 million by 2029, growing at
Published: 2023-12-29
Pages: 74
USD 3350.00
(Single User License)
Oral Rabies Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Oral Rabies Vaccine was estimated to be worth US$ 80 million in 2023 and is fo
Published: 2024-02-19
Pages: 82
USD 3950.00
(Single User License)
Global Oral Rabies Vaccine Market Research Report 2025
The global market for Oral Rabies Vaccine was valued at US$ 116 million in the year 2024 and is proj
Published: 2025-03-02
Pages: 70
USD 2900.00
(Single User License)